Specifies that professional liability insurance insurers cannot deny coverage or increase rates solely based on legal use or prescription of certain gender-affirming care-related drugs; prescribes procedures for warrants issued in other jurisdictions for electronic data related to legally protected health activities; provides for additional procedural methods for protection of legally protected health activities.
Impact
The bill could significantly impact state laws relating to medical malpractice and professional liability insurance. By prohibiting adverse actions against healthcare providers based on the medications they prescribe, S08807 seeks to protect patient access to gender-affirming care and abortion services. This could lead to a more supportive environment for both providers and patients in the state of New York, especially in a landscape where similar protections may vary significantly across jurisdictions.
Summary
Bill S08807 focuses on the reform of insurance regulations related to gender-affirming care and certain pharmacological treatments. Specifically, the bill disallows insurers from denying coverage or increasing premiums based solely on the legal prescription of gender-affirming medications and drugs used for abortion, whether or not they are FDA approved. This change aims to enhance access to necessary healthcare services for individuals requiring these treatments by ensuring their providers are not penalized through insurance coverage decisions.
Contention
While supporters argue that this bill addresses essential healthcare rights and protections for individuals seeking gender-affirming care and reproductive health services, there may be points of contention surrounding its implications for insurance companies and healthcare providers. Critics could argue it places undue burdens on insurers or conflicts with federal regulations, especially in areas where state laws diverge from national policies. Moreover, the operational impact on healthcare providers must be considered, including the potential increase in litigation risks if insurers do not adhere to the new regulations.
Same As
Specifies that professional liability insurance insurers cannot deny coverage or increase rates solely based on legal use or prescription of certain gender-affirming care-related drugs; prescribes procedures for warrants issued in other jurisdictions for electronic data related to legally protected health activities; provides for additional procedural methods for protection of legally protected health activities.
Specifies that professional liability insurance insurers cannot deny coverage or increase rates solely based on legal use or prescription of certain gender-affirming care-related drugs; prescribes procedures for warrants issued in other jurisdictions for electronic data related to legally protected health activities; provides for additional procedural methods for protection of legally protected health activities.
Protects individuals who provide or receive legally protected health activity, including reproductive health care and gender-affirming care, from criminal or civil liability or professional sanctions imposed by jurisdictions outside the state.
Requires health insurance and Medicaid coverage for family planning and reproductive health care services; prohibits adverse actions by medical malpractice insurers in relation to performance of legally protected health care services.
Requires health insurance and Medicaid coverage for family planning and reproductive health care services; prohibits adverse actions by medical malpractice insurers in relation to performance of legally protected health care services.
Protects individuals who provide or receive legally protected health activity, including reproductive health care and gender-affirming care, from criminal or civil liability or professional sanctions imposed by jurisdictions outside the state.